A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome

Jack J H Bleesing, Margaret R. Brown, Cynthia Novicio, David Guarraia, Janet K. Dale, Stephen E. Straus, Thomas A. Fleisher

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The discovery of an unusual T-cell subset characterized by the expression of the α/β T-cell receptor without expression of either CD4 or CD8 [α/β-double-negative T cells (α/β-DNTCs)] provided critical insights in the evaluation of a "new" lymphoproliferative disorder known as autoimmune lymphoproliferative syndrome (ALPS). ALPS is a disorder of defective Fas-mediated lymphocyte apoptosis, manifested by accumulation of α/β-DNTCs and other lymphocyte subsets, leading to lymphadenopathy and splenomegaly, autoimmunity, and an increased risk of lymphoma. The expanded population of α/β-DNTCs from ALPS patients has a remarkable uniform phenotype that is for the most part similar to α/β-DNTCs from mice with defective Fas (lpr) or Fas ligand (gld). This is in contrast to the minor α/β-DNTC compartment in healthy individuals that contains multiple, immunophenotypically distinct subpopulations. Current data indicate that α/β-DNTCs from ALPS patients are derived from cytotoxic CD8+ T cells, chronically activated in vivo but anergic in vitro. Their anergic state may be related to persistent modifications of O-linked carbohydrates on cell surface molecules, such as CD43 and CD45, as well as to the increased presence of interleukin-10. Although largely consistent with a model of (linear) CD8+ cytotoxic T-cell differentiation, the expression patterns of certain surface molecules, such as CD27 and CD28, are not consistent with this model. This may be the result of the perturbed homeostasis of lymphocytes in ALPS, thereby revealing pathways of differentiation and immunophenotypes, including phenotypes pertaining to cell surface glycosylation that are hidden from view in healthy individuals.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalClinical Immunology
Volume104
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Autoimmune Lymphoproliferative Syndrome
T-Lymphocytes
Lymphocytes
Phenotype
Fas Ligand Protein
Lymphoproliferative Disorders
Splenomegaly
Lymphocyte Subsets
T-Lymphocyte Subsets
T-Cell Antigen Receptor
Autoimmunity
Glycosylation
Interleukin-10
Cell Differentiation
Linear Models
Lymphoma
Homeostasis
Carbohydrates
4-N,N-dimethylamino-1-naphthylisothiocyanate
Apoptosis

Keywords

  • Apoptosis
  • Auto-immunity
  • CD45
  • Cell surface molecules
  • Human
  • Lymphoproliferation
  • O-glycans
  • T lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome. / Bleesing, Jack J H; Brown, Margaret R.; Novicio, Cynthia; Guarraia, David; Dale, Janet K.; Straus, Stephen E.; Fleisher, Thomas A.

In: Clinical Immunology, Vol. 104, No. 1, 2002, p. 21-30.

Research output: Contribution to journalArticle

Bleesing, Jack J H ; Brown, Margaret R. ; Novicio, Cynthia ; Guarraia, David ; Dale, Janet K. ; Straus, Stephen E. ; Fleisher, Thomas A. / A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome. In: Clinical Immunology. 2002 ; Vol. 104, No. 1. pp. 21-30.
@article{a3bc3fd4673d406fbf6312ed3b10c67a,
title = "A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome",
abstract = "The discovery of an unusual T-cell subset characterized by the expression of the α/β T-cell receptor without expression of either CD4 or CD8 [α/β-double-negative T cells (α/β-DNTCs)] provided critical insights in the evaluation of a {"}new{"} lymphoproliferative disorder known as autoimmune lymphoproliferative syndrome (ALPS). ALPS is a disorder of defective Fas-mediated lymphocyte apoptosis, manifested by accumulation of α/β-DNTCs and other lymphocyte subsets, leading to lymphadenopathy and splenomegaly, autoimmunity, and an increased risk of lymphoma. The expanded population of α/β-DNTCs from ALPS patients has a remarkable uniform phenotype that is for the most part similar to α/β-DNTCs from mice with defective Fas (lpr) or Fas ligand (gld). This is in contrast to the minor α/β-DNTC compartment in healthy individuals that contains multiple, immunophenotypically distinct subpopulations. Current data indicate that α/β-DNTCs from ALPS patients are derived from cytotoxic CD8+ T cells, chronically activated in vivo but anergic in vitro. Their anergic state may be related to persistent modifications of O-linked carbohydrates on cell surface molecules, such as CD43 and CD45, as well as to the increased presence of interleukin-10. Although largely consistent with a model of (linear) CD8+ cytotoxic T-cell differentiation, the expression patterns of certain surface molecules, such as CD27 and CD28, are not consistent with this model. This may be the result of the perturbed homeostasis of lymphocytes in ALPS, thereby revealing pathways of differentiation and immunophenotypes, including phenotypes pertaining to cell surface glycosylation that are hidden from view in healthy individuals.",
keywords = "Apoptosis, Auto-immunity, CD45, Cell surface molecules, Human, Lymphoproliferation, O-glycans, T lymphocytes",
author = "Bleesing, {Jack J H} and Brown, {Margaret R.} and Cynthia Novicio and David Guarraia and Dale, {Janet K.} and Straus, {Stephen E.} and Fleisher, {Thomas A.}",
year = "2002",
doi = "10.1006/clim.2002.5225",
language = "English (US)",
volume = "104",
pages = "21--30",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome

AU - Bleesing, Jack J H

AU - Brown, Margaret R.

AU - Novicio, Cynthia

AU - Guarraia, David

AU - Dale, Janet K.

AU - Straus, Stephen E.

AU - Fleisher, Thomas A.

PY - 2002

Y1 - 2002

N2 - The discovery of an unusual T-cell subset characterized by the expression of the α/β T-cell receptor without expression of either CD4 or CD8 [α/β-double-negative T cells (α/β-DNTCs)] provided critical insights in the evaluation of a "new" lymphoproliferative disorder known as autoimmune lymphoproliferative syndrome (ALPS). ALPS is a disorder of defective Fas-mediated lymphocyte apoptosis, manifested by accumulation of α/β-DNTCs and other lymphocyte subsets, leading to lymphadenopathy and splenomegaly, autoimmunity, and an increased risk of lymphoma. The expanded population of α/β-DNTCs from ALPS patients has a remarkable uniform phenotype that is for the most part similar to α/β-DNTCs from mice with defective Fas (lpr) or Fas ligand (gld). This is in contrast to the minor α/β-DNTC compartment in healthy individuals that contains multiple, immunophenotypically distinct subpopulations. Current data indicate that α/β-DNTCs from ALPS patients are derived from cytotoxic CD8+ T cells, chronically activated in vivo but anergic in vitro. Their anergic state may be related to persistent modifications of O-linked carbohydrates on cell surface molecules, such as CD43 and CD45, as well as to the increased presence of interleukin-10. Although largely consistent with a model of (linear) CD8+ cytotoxic T-cell differentiation, the expression patterns of certain surface molecules, such as CD27 and CD28, are not consistent with this model. This may be the result of the perturbed homeostasis of lymphocytes in ALPS, thereby revealing pathways of differentiation and immunophenotypes, including phenotypes pertaining to cell surface glycosylation that are hidden from view in healthy individuals.

AB - The discovery of an unusual T-cell subset characterized by the expression of the α/β T-cell receptor without expression of either CD4 or CD8 [α/β-double-negative T cells (α/β-DNTCs)] provided critical insights in the evaluation of a "new" lymphoproliferative disorder known as autoimmune lymphoproliferative syndrome (ALPS). ALPS is a disorder of defective Fas-mediated lymphocyte apoptosis, manifested by accumulation of α/β-DNTCs and other lymphocyte subsets, leading to lymphadenopathy and splenomegaly, autoimmunity, and an increased risk of lymphoma. The expanded population of α/β-DNTCs from ALPS patients has a remarkable uniform phenotype that is for the most part similar to α/β-DNTCs from mice with defective Fas (lpr) or Fas ligand (gld). This is in contrast to the minor α/β-DNTC compartment in healthy individuals that contains multiple, immunophenotypically distinct subpopulations. Current data indicate that α/β-DNTCs from ALPS patients are derived from cytotoxic CD8+ T cells, chronically activated in vivo but anergic in vitro. Their anergic state may be related to persistent modifications of O-linked carbohydrates on cell surface molecules, such as CD43 and CD45, as well as to the increased presence of interleukin-10. Although largely consistent with a model of (linear) CD8+ cytotoxic T-cell differentiation, the expression patterns of certain surface molecules, such as CD27 and CD28, are not consistent with this model. This may be the result of the perturbed homeostasis of lymphocytes in ALPS, thereby revealing pathways of differentiation and immunophenotypes, including phenotypes pertaining to cell surface glycosylation that are hidden from view in healthy individuals.

KW - Apoptosis

KW - Auto-immunity

KW - CD45

KW - Cell surface molecules

KW - Human

KW - Lymphoproliferation

KW - O-glycans

KW - T lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0036334807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036334807&partnerID=8YFLogxK

U2 - 10.1006/clim.2002.5225

DO - 10.1006/clim.2002.5225

M3 - Article

C2 - 12139944

AN - SCOPUS:0036334807

VL - 104

SP - 21

EP - 30

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -